OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

PROGRESSIVE CORP. DL 1/  US7433151039  /

Düsseldorf
2024-09-24  8:10:12 AM Chg. -0.85 Volume Bid3:57:46 PM Ask3:57:46 PM Market Capitalization Dividend Y. P/E Ratio
230.80EUR -0.37% 0
Turnover: 0.00		 228.25Bid Size: 110 229.20Ask Size: 110 134.08 bill.EUR - -
Newsfile Corp 09-19 Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Newsfile Corp 09-17 Innovation Driving Cancer's Solid Tumors Market
GlobeNewswire 09-02 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 08-30 MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire 08-30 Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire 08-29 The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire 08-28 AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire 08-26 Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire 08-22 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 08-21 CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire 08-19 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 08-19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 08-19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 08-19 CN Issues Lockout Notice to Teamsters
GlobeNewswire 08-15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 08-14 Progressive Reports July 2024 Results
GlobeNewswire 08-14 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 08-14 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 08-13 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 08-12 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 08-12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 08-11 Bank of Russia says rates could reach 20%
GlobeNewswire 08-08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 08-08 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 08-07 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...